Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative toOpen Heart Surgery for Select Patients with Left Main Coronary Artery Disease
Cardiovascular Research Foundation (CRF)A large-scale randomized trial examining percutaneous coronary intervention (PCI) versus coronary artery bypass graft surgery (CABG) in patients with left main coronary artery disease (LMCAD) and low-intermediate SYNTAX scores found that there was no significant difference in three-year outcomes between the two treatments, with a reduction in 30-day major adverse events with PCI.